|
ACS Nano
|
7 |
4.46 |
|
|
|
Acta Biomaterialia
|
1 |
1.00 |
|
|
|
Advanced Functional Materials
|
2 |
1.00 |
|
|
|
Advanced Materials
|
2 |
2.00 |
|
|
|
American Journal of Epidemiology
|
1 |
0.56 |
|
|
|
American Journal of Human Genetics
|
1 |
0.69 |
|
|
|
American Journal of Pathology
|
3 |
1.94 |
|
|
|
American Journal of Respiratory and Critical Care Medicine
|
5 |
3.36 |
|
|
|
Angewandte Chemie International Edition
|
1 |
0.08 |
|
|
|
Annals of Neurology
|
3 |
1.41 |
|
|
|
Annals of the Rheumatic Diseases
|
5 |
2.42 |
|
|
|
Arthritis & Rheumatology
|
9 |
7.41 |
|
|
|
Blood
|
16 |
11.40 |
|
|
|
Cancer Cell
|
11 |
7.78 |
|
|
|
Cancer Research
|
17 |
9.16 |
|
|
|
Cell
|
17 |
13.80 |
|
|
|
Cell Host & Microbe
|
9 |
6.91 |
|
|
|
Chest
|
1 |
1.00 |
|
|
|
Circulation
|
2 |
1.38 |
|
|
|
Clinical Infectious Diseases
|
9 |
7.27 |
|
Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345
|
0.77 |
|
Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness
|
1.00 |
|
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
|
0.75 |
|
Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV
|
0.90 |
|
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients
|
0.56 |
|
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant
|
0.80 |
|
IL12RB1 Deficiency Appearing in North America: Expanding the Clinical Phenotypes
|
1.00 |
|
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18–64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8
|
0.50 |
|
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years
|
1.00 |
|
|
Critical Care Medicine
|
2 |
1.96 |
|
|
|
Current Biology
|
1 |
1.00 |
|
|
|
Diabetes Care
|
2 |
2.00 |
|
|
|
Environmental Pollution
|
1 |
1.00 |
|
|
|
Environmental Research
|
2 |
1.08 |
|
|
|
Environmental Science and Technology
|
4 |
1.20 |
|
|
|
European Heart Journal
|
1 |
0.38 |
|
|
|
Gastroenterology
|
2 |
2.00 |
|
|
|
Genes & Development
|
2 |
1.89 |
|
|
|
Genome Research
|
2 |
1.86 |
|
|
|
Gut
|
2 |
0.19 |
|
|
|
Hepatology
|
4 |
1.94 |
|
|
|
Human Reproduction
|
1 |
0.86 |
|
|
|
Immunity
|
46 |
38.84 |
|
|
|
International Journal of Epidemiology
|
1 |
1.00 |
|
|
|
JAMA Pediatrics
|
1 |
0.39 |
|
|
|
JAMA: The Journal of the American Medical Association
|
2 |
1.79 |
|
|
|
Journal of Biological Chemistry
|
21 |
16.20 |
|
|
|
Journal of Cell Biology
|
3 |
2.05 |
|
|
|
Journal of Clinical Endocrinology & Metabolism
|
2 |
1.24 |
|
|
|
Journal of Clinical Investigation
|
43 |
32.67 |
|
|
|
Journal of Clinical Oncology
|
6 |
5.94 |
|
|
|
Journal of Experimental Medicine
|
44 |
24.93 |
|
|
|
Journal of Infectious Diseases
|
17 |
13.78 |
|
|
|
Journal of Physiology
|
3 |
2.39 |
|
|
|
Journal of Thoracic and Cardiovascular Surgery
|
1 |
1.00 |
|
|
|
Journal of the American Academy of Dermatology
|
1 |
1.00 |
|
|
|
Journal of the American Chemical Society
|
1 |
0.96 |
|
|
|
Journal of the American Society of Nephrology
|
2 |
1.14 |
|
|
|
Kidney International
|
6 |
4.21 |
|
|
|
Molecular Cell
|
2 |
2.00 |
|
|
|
Molecular Psychiatry
|
3 |
0.22 |
|
|
|
Nano Letters
|
1 |
1.00 |
|
|
|
Nature
|
34 |
28.74 |
|
|
|
Nature Cell Biology
|
4 |
1.91 |
|
|
|
Nature Chemical Biology
|
3 |
3.00 |
|
|
|
Nature Communications
|
127 |
93.95 |
|
Molecular mechanisms for subtype selectivity of kinin receptors’ antagonists
|
0.67 |
|
PD-1 regulates latent effector differentiation of thymic cytotoxic CD8 T cells
|
1.00 |
|
Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models
|
0.09 |
|
TRIM21 facilitates inflammasome assembly and contributes to autoinflammatory disease
|
1.00 |
|
microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3
|
1.00 |
|
TaRGET II Data Portal: a multi-omics resource for environmental toxicant studies in mice
|
1.00 |
|
Rank-dependent control of tuft and BEST4 cell development in the intestine
|
0.20 |
|
Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution
|
1.00 |
|
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer
|
0.83 |
|
Efficacy and durability of immediate versus delayed single-dose HPV vaccination for persistent infection among young women in Kenya: a randomized, blinded, cross-over clinical trial
|
0.66 |
|
Cell death modalities modulate inflammatory and regenerative programs in zebrafish sensory organs
|
1.00 |
|
Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity
|
0.12 |
|
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer
|
1.00 |
|
Molecular architecture of the fungal-specific potassium channel TOK1
|
1.00 |
|
IFNγ blockade in Mycobacterium tuberculosis infected macaques alters the granuloma environment but not bacterial control
|
0.76 |
|
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trial
|
1.00 |
|
In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer
|
1.00 |
|
Poor sleep impairs immune responses and influenza vaccine protection
|
0.92 |
|
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma
|
0.05 |
|
CD4+ T cell protection against murine Salmonella infection is female-specific and estrogen-dependent
|
1.00 |
|
Early life exposure to -nitrosamine drives genotoxicity, mutagenesis, and tumorigenesis in DNA repair-deficient mice
|
0.92 |
|
Multiomics-guided discovery of protective microbiome signatures in lupus-prone mice treated with Faecalibacterium prausnitzii
|
1.00 |
|
β2 adrenergic receptors orchestrate neutrophil demargination and recruitment to the ischemic heart following myocardial infarction
|
0.71 |
|
Complete inhibition of β-tryptase by tetramer dissociation and active site allostery due to a single antibody residue
|
1.00 |
|
Dissecting PGE2-driven inhibition of T cell activation using single-cell multi-omic and inflammatory bowel disease genetic association analysis
|
0.89 |
|
Tim-3 agonist restrains ILC2 function and attenuates airway hyperreactivity via NLK pathway
|
1.00 |
|
Compartmentalized cytoplasmic tradewinds direct soluble proteins
|
1.00 |
|
Tuft cells shape airway remodeling by eliciting OXGR1- and SOX9-dependent stem cell programs
|
1.00 |
|
Antigen-specific immunotherapy with a CD4+ T cell neoepitope restrains CD8+ T cell differentiation in murine pancreatic islet grafts
|
1.00 |
|
CD8+ T cells sustain vaccination-induced immunity against dissemination of contained tuberculosis in immunosuppressed hosts
|
0.05 |
|
Mining antibody functionality via AI-guided structural landscape profiling
|
0.11 |
|
Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells
|
1.00 |
|
TYK2 mediates neuroinflammation in Alzheimer’s disease brains with TDP-43 pathology
|
0.88 |
|
A conserved, immune-regulated peritrophin promotes Vibrio cholerae colonization of the arthropod intestine
|
1.00 |
|
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits
|
1.00 |
|
CD8 T cell loss induces autoinflammation in inborn errors of cell death
|
0.14 |
|
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma
|
1.00 |
|
Lyn governs the establishment and maintenance of B cell anergy by suppressing PI3K signaling
|
1.00 |
|
Evolving epigenomics of immune cells at single-nucleus resolution in children en route to type 1 diabetes
|
0.64 |
|
Idiotype-specific CD4+ T cells chronically stimulate autoreactive B cells to develop into B lymphomas in mice
|
0.10 |
|
Stem-like memory-T maintenance and differentiation into tissue-resident T cells sustain chronic graft-versus-host disease in mice
|
0.93 |
|
A multi-center clinical trial of allogeneic hematopoietic stem cell transplantation in transfusion-dependent thalassemia
|
0.03 |
|
RORγt APCs require a distinct cis-regulatory element to instruct tolerance to dietary antigens
|
0.18 |
|
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways
|
0.96 |
|
Negative feedback regulation of STING signaling by TAX1BP1-directed Golgiphagy
|
1.00 |
|
Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression
|
1.00 |
|
Positive cooperativity between RAS-binding and cysteine-rich domains regulates RAF membrane binding kinetics via lateral rebinding
|
1.00 |
|
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development
|
1.00 |
|
Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA
|
1.00 |
|
Atypical pericapillary Ly6G⁺Nur77⁺ macrophages initiate type-2 immune responses to allergens in the mouse lung
|
1.00 |
|
Intelectin-2 is a broad-spectrum antimicrobial lectin
|
1.00 |
|
Butyrophilin 2A2 promotes T cell immunoregulation via CD45 phosphatase activation and protects against murine autoimmune glomerulonephritis and pregnancy loss
|
1.00 |
|
Chronic macrophage activation derails muscle repair by disrupting mannose-receptor-linked plasticity revealed by endogenous tracking
|
1.00 |
|
The inflammatory path toward type 1 diabetes begins during pregnancy
|
0.50 |
|
Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming
|
1.00 |
|
Sideways lipid presentation by the antigen-presenting molecule CD1c
|
0.17 |
|
IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice
|
1.00 |
|
Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
|
1.00 |
|
Distinct gastrointestinal microbial signatures predict parasite levels in controlled Plasmodium infections in both rhesus macaques and humans
|
1.00 |
|
Resistance potential of the HLA-A2-restricted immunodominant SARS-CoV-2-specific CD8+ T cell receptor repertoire to antigenic drift
|
0.75 |
|
Ataxin-2-like promotes translation of nonpolyadenylated reovirus mRNA
|
1.00 |
|
The resting and ligand-bound states of the membrane-embedded human T-cell receptor–CD3 complex
|
1.00 |
|
Structural basis for ACT1 oligomerization induced by IL-17 receptor hetero-tetramer
|
1.00 |
|
Aiolos restricts the generation of antigen-inexperienced, virtual memory CD8+ T cells in mice
|
1.00 |
|
Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease
|
0.89 |
|
Double stranded RNA sensing is silenced during early embryonic development
|
0.04 |
|
Structural basis of PANX1 permeation and positive modulation by mefloquine
|
1.00 |
|
Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes
|
0.36 |
|
Discovery of a small molecule TLR3 agonist adjuvant
|
1.00 |
|
Characterization of Anopheles gambiae immune cells through genetic and functional immunophenotyping
|
1.00 |
|
Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity
|
0.32 |
|
Platelet-mediated activation of perivascular mast cells triggers progression of sepsis to septic shock in mice
|
0.82 |
|
A spatial atlas of the complement system uncovers unique expression patterns in postnatal brain development in mice
|
1.00 |
|
The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors
|
0.71 |
|
Germline polymorphisms in the immunoglobulin kappa and lambda loci underpinning antibody light chain repertoire variability
|
1.00 |
|
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2
|
0.13 |
|
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection
|
0.16 |
|
Atomic mechanisms of full-length ASC-mediated inflammasome assembly
|
0.13 |
|
Epigenetic and transcriptional programming of murine eosinophils in the esophagus
|
0.90 |
|
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma
|
0.11 |
|
Relationships among host genetics, gut microbiota, and asthma in US Hispanic/Latino adults
|
1.00 |
|
A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection
|
1.00 |
|
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
|
1.00 |
|
A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors
|
1.00 |
|
Gut-primed neutrophils activate Kupffer cells to promote hepatic injury in mouse sepsis
|
1.00 |
|
Gut bacterial dysbiosis in pediatric severe malaria associates with post-discharge mortality
|
0.62 |
|
A Rho GTPase-effector ensemble governs cell migration behavior
|
0.14 |
|
Specification curve analysis of the TEDDY study reveals large variation in microbiome-based T1D predictive performance
|
1.00 |
|
APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling
|
0.87 |
|
A pan-immunotherapy signature to predict intratumoral CD8+ T cell expansions
|
0.03 |
|
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19
|
0.67 |
|
Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines
|
0.17 |
|
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice
|
1.00 |
|
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
|
0.35 |
|
Paraventricular nucleus CRH neurons regulate acute lung injury via sympathetic nerve–neutrophil axis
|
0.10 |
|
Macrophage WDFY3 mitigates autoimmunity by enhancing efferocytosis and suppressing T cell activation in mice
|
1.00 |
|
A loss-of-function human ADAR variant activates innate immune response and promotes bowel inflammation
|
0.72 |
|
GM-CSF-dependent CD301b+ mouse lung dendritic cells confer tolerance to inhaled allergens
|
1.00 |
|
Physiologic Homeostasis in a Living Human after Pig Kidney Xenotransplantation
|
0.98 |
|
A specific gene expression program underlies antigen archiving by lymphatic endothelial cells in mammalian lymph nodes
|
1.00 |
|
NR3C1-mediated epigenetic regulation suppresses astrocytic immune responses in mice
|
0.20 |
|
A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor
|
0.13 |
|
Chronic social defeat stress induces meningeal neutrophilia via type I interferon signaling in male mice
|
0.76 |
|
Prefoldin complex promotes interferon-stimulated gene expression and is inhibited by rotavirus VP3
|
0.92 |
|
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults
|
0.07 |
|
Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2
|
0.11 |
|
CYP1B1-AS1 regulates CYP1B1 to promote Coxiella burnetii pathogenesis by inhibiting ROS and host cell death
|
1.00 |
|
A citrullinated histone H3 monoclonal antibody for immune modulation in sepsis
|
0.90 |
|
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target
|
0.03 |
|
Urinary Complement proteome strongly linked to diabetic kidney disease progression
|
1.00 |
|
The spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigra
|
1.00 |
|
Intestinal CD4−CD8αβ−TCRαβ+ T cells function as tolerogenic antigen presenting cells in mice
|
0.09 |
|
Macrophage-T cell interactions promote SLAMF1 expression for enhanced TB defense
|
1.00 |
|
Integrin CD103 reveals a distinct developmental pathway of autoreactive thymocytes in TCR transgenic mice
|
1.00 |
|
A glyoxal-specific aldehyde signaling axis in Pseudomonas aeruginosa that influences quorum sensing and infection
|
1.00 |
|
Variable lymphocyte receptor F is generated via somatic diversification and expressed by lamprey T-like cells
|
0.80 |
|
Antigen specificity shapes distinct aging trajectories of memory CD8⁺ T cells
|
0.97 |
|
Imaging of macrophage accumulation in solid tumors with ultrasound
|
1.00 |
|
Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma
|
0.40 |
|
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts
|
0.12 |
|
Modeling heterogeneous signaling dynamics of macrophages reveals principles of information transmission in stimulus responses
|
1.00 |
|
Generating combinatorial diversity via engineered V(D)J-like recombination in Saccharomyces cerevisiae
|
1.00 |
|
Orthosteric STING inhibition elucidates molecular correction of SAVI STING
|
0.94 |
|
Circulating cell-free DNA methylation patterns indicate cellular sources of allograft injury after liver transplant
|
1.00 |
|
Single cell profiling of human airway identifies tuft-ionocyte progenitor cells displaying cytokine-dependent differentiation bias in vitro
|
1.00 |
|
Androgens inhibit protective CD8 T cell responses against pre-erythrocytic malaria parasites in mice
|
1.00 |
|
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth
|
0.08 |
|
|
Nature Genetics
|
4 |
2.64 |
|
|
|
Nature Immunology
|
64 |
45.70 |
|
|
|
Nature Materials
|
1 |
1.00 |
|
|
|
Nature Medicine
|
9 |
4.51 |
|
|
|
Nature Methods
|
1 |
1.00 |
|
|
|
Nature Nanotechnology
|
1 |
0.93 |
|
|
|
Nature Structural & Molecular Biology
|
1 |
1.00 |
|
|
|
Neuron
|
1 |
1.00 |
|
|
|
PLOS Biology
|
5 |
4.31 |
|
|
|
PLOS Genetics
|
1 |
1.00 |
|
|
|
PLOS Medicine
|
1 |
0.03 |
|
|
|
Physical Review Letters
|
1 |
0.17 |
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
|
92 |
74.34 |
|
|
|
Science
|
20 |
15.91 |
|
|
|
Science Advances
|
52 |
39.29 |
|
|
|
Science Translational Medicine
|
12 |
10.89 |
|
|
|
The EMBO Journal
|
10 |
4.86 |
|
|
|
The ISME Journal: Multidisciplinary Journal of Microbial Ecology
|
1 |
0.10 |
|
|
|
The Journal of Allergy and Clinical Immunology
|
36 |
25.90 |
|
|
|
The Lancet
|
1 |
0.47 |
|
|
|
The Lancet Diabetes & Endocrinology
|
1 |
0.13 |
|
|
|
The New England Journal of Medicine
|
15 |
6.77 |
|
|